Financials UG Healthcare Corporation Limited
Equities
8K7
SGXE48766716
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 SGD | -1.79% | 0.00% | -34.13% |
Feb. 16 | UG Healthcare Grants 2.8 Million Share Options | MT |
Feb. 14 | UG Healthcare's Fiscal H1 Loss Widens as Revenue Drops on Lower Latex Glove Prices; Shares Fall 5% | MT |
Valuation
Fiscal Period: Junio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 44.03 | 33.05 | 231.4 | 354.3 | 137.2 | 89.83 |
Enterprise Value (EV) 1 | 64.14 | 66.52 | 257.7 | 302.7 | 55 | 59.21 |
P/E ratio | 10.2 x | 13.3 x | 17.4 x | 2.96 x | 3.71 x | -4.33 x |
Yield | 1.04% | 1.58% | 0.61% | 0.71% | 1.45% | - |
Capitalization / Revenue | 0.56 x | 0.36 x | 1.6 x | 1.05 x | 0.59 x | 0.89 x |
EV / Revenue | 0.82 x | 0.73 x | 1.79 x | 0.89 x | 0.24 x | 0.59 x |
EV / EBITDA | 18.1 x | 12.7 x | 9.58 x | 1.91 x | 1.01 x | -2.64 x |
EV / FCF | -8.1 x | -4.64 x | 27.5 x | 6.31 x | 4.48 x | -2.98 x |
FCF Yield | -12.4% | -21.5% | 3.64% | 15.9% | 22.3% | -33.6% |
Price to Book | 1.05 x | 0.78 x | 4.43 x | 1.86 x | 0.6 x | 0.5 x |
Nbr of stocks (in thousands) | 574,380 | 579,893 | 588,279 | 616,259 | 623,826 | 623,826 |
Reference price 2 | 0.0767 | 0.0570 | 0.3933 | 0.5750 | 0.2200 | 0.1440 |
Announcement Date | 10/8/18 | 10/8/19 | 10/8/20 | 10/14/21 | 10/13/22 | 10/12/23 |
Income Statement Evolution (Annual data)
Fiscal Period: Junio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 78.06 | 91.71 | 144.2 | 338.4 | 232.6 | 101.1 |
EBITDA 1 | 3.552 | 5.254 | 26.89 | 158.3 | 54.21 | -22.41 |
EBIT 1 | 2.111 | 3.631 | 24.8 | 155.8 | 51.17 | -25.12 |
Operating Margin | 2.7% | 3.96% | 17.2% | 46.04% | 22% | -24.84% |
Earnings before Tax (EBT) 1 | 5.047 | 2.763 | 18.06 | 159.4 | 48.76 | -28.36 |
Net income 1 | 4.335 | 2.507 | 13.4 | 118.8 | 36.8 | -20.73 |
Net margin | 5.55% | 2.73% | 9.29% | 35.1% | 15.82% | -20.5% |
EPS 2 | 0.007500 | 0.004300 | 0.0226 | 0.1942 | 0.0593 | -0.0332 |
Free Cash Flow 1 | -7.923 | -14.33 | 9.383 | 47.99 | 12.28 | -19.89 |
FCF margin | -10.15% | -15.63% | 6.51% | 14.18% | 5.28% | -19.67% |
FCF Conversion (EBITDA) | - | - | 34.89% | 30.32% | 22.66% | - |
FCF Conversion (Net income) | - | - | 70.01% | 40.41% | 33.38% | - |
Dividend per Share 2 | 0.000800 | 0.000900 | 0.002400 | 0.004060 | 0.003200 | - |
Announcement Date | 10/8/18 | 10/8/19 | 10/8/20 | 10/14/21 | 10/13/22 | 10/12/23 |
Balance Sheet Analysis
Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 20.1 | 33.5 | 26.4 | - | - | - |
Net Cash position 1 | - | - | - | 51.7 | 82.2 | 30.6 |
Leverage (Debt/EBITDA) | 5.661 x | 6.37 x | 0.9802 x | - | - | - |
Free Cash Flow 1 | -7.92 | -14.3 | 9.38 | 48 | 12.3 | -19.9 |
ROE (net income / shareholders' equity) | 10.9% | 5.2% | 30.9% | 96.3% | 18.5% | -13% |
ROA (Net income/ Total Assets) | 1.74% | 2.46% | 14.6% | 51.1% | 11.5% | -6.06% |
Assets 1 | 248.8 | 101.8 | 91.69 | 232.6 | 320.1 | 342.1 |
Book Value Per Share 2 | 0.0700 | 0.0700 | 0.0900 | 0.3100 | 0.3700 | 0.2900 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0.0200 | 0.1100 | 0.1600 | 0.1000 |
Capex 1 | 4.68 | 8.53 | 3.29 | 18 | 20.7 | 7.69 |
Capex / Sales | 5.99% | 9.3% | 2.28% | 5.31% | 8.92% | 7.6% |
Announcement Date | 10/8/18 | 10/8/19 | 10/8/20 | 10/14/21 | 10/13/22 | 10/12/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.13% | 50.36M | |
+11.84% | 27.79B | |
-32.98% | 2.98B | |
-15.97% | 2.52B | |
+11.90% | 2.34B | |
-1.11% | 1.91B | |
-13.37% | 1.83B | |
-7.78% | 1.39B | |
-0.38% | 1.27B | |
+4.01% | 1.13B |
- Stock Market
- Equities
- 8K7 Stock
- Financials UG Healthcare Corporation Limited